Business Wire

Reports Net Investment Income of $0.56 per Share

Declares Second Quarter Regular Distribution of $0.45 per Share

NEW YORK--(BUSINESS WIRE)-- Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) (“NCDL” or the “Company”), a business development company externally managed by its investment adviser, Churchill DLC Advisor LLC (the “Adviser”), and by its sub-adviser, Churchill Asset Management LLC (“Churchill”), today reported financial results for the... (continue reading...)

CLEARWATER, Fla.--(BUSINESS WIRE)-- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today reported financial results for its first quarter ended March 31, 2024; and reaffirmed its financial expectations for the full year ending December 31, 2024.

First Quarter 2024 Financial Summary:

• Total revenue of $10.2 million, a... (continue reading...)

SPT-300 demonstrated nine times greater allopregnanolone exposure in humans dosed orally than published data for oral allopregnanolone,1 validating Glyph™ platform’s ability to enhance oral bioavailability

In a Phase 2a trial, SPT-3002 substantially reduced stress-induced levels of cortisol, supporting Seaport’s planned studies in mood and anxiety disorders, including anxious depression

BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: ... (continue reading...)

Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award for Best New Technology Solution in the Cardiology category. The recognition is for Anumana’s suite of artificial... (continue reading...)

Outlines Accelerated AI Product Strategy and Roadmap

• Reports Q1 2024 total revenues of $32.1 million and adjusted EBITDA of $1.2 million(1), both slightly exceeding previously provided guidance
• Reaffirms forecast for FY 2024 and issues forecast for Q2 2024
• Successfully completes Board.org divestiture for a total consideration of up to $103.0 million
• Accelerates its strategy of developing revolutionary AI Copilots to transform Legal, Regulatory, and Policy... (continue reading...)